PMDA’s Review-Related Ordinary Loss Nearly Doubled in FY2016

June 28, 2017
PMDA Chief Executive Tatsuya Kondo (center) The Pharmaceuticals and Medical Devices Agency (PMDA) announced on June 26 at its steering committee meeting that the ordinary loss related to its review division nearly doubled to 1,888 million yen in FY2016. The...read more